CDK4/6-IN-17
CDK4/6-IN-17 (Compound 12) is a CDK4/6 inhibitor (IC50: 50: 10-100 nM) . CDK4/6-IN-17 inhibits tumor growth in COLO205 xenograft tumors[1].
Product Specifications
CAS Number
2035069-96-4
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk4-6-in-17.html
Solubility
10 mM in DMSO
Smiles
FC([C@H]1N2C3=CC(C4=NC(NC5=CC=C(C=N5)CN6CCN(CC6)CC)=NC=C4F)=CC(F)=C3N=C2CC1)F
Molecular Formula
C27H28F4N8
Molecular Weight
540.56
References & Citations
[1]Zhao X, et al. Preparation of benzopyrroloimidazolyl compounds as CDK4/6 kinase inhibitors. World Intellectual Property Organization, WO2016173505 A1. 2016-11-03.|[2]Zhao Xingdong. A kind of kinase inhibitor. Patent. CN107849012.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY423828 100 µg
HMGN2P46 (NM_001005269) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC402057-100 1x 100 µL
HPV-16 (Human Papilloma Virus 16) (rHPV16L1/1058), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940979-500 1x 500 µL
Cytokeratin 8/18 (KRT8/803 + KRT18/835), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 